Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study: Insulin sensitivity/secretion indices in youth T2DM
Year: 2012
Type: article
Abstract: OBJECTIVE: To investigate insulin sensitivity and secretion indices and determinants of glycemic control in youth with recent-onset type 2 diabetes (T2DM) at randomization in the TODAY study, the largest study of youth with T2DM to date. METHODS: We examined estimates of insulin sensitivity [1/fasting insulin (1/I(F)), fasting glucose/insulin (G(F) /I(F)), 1/fasting C-peptide (1/C(F)), G(F) /C(F)], β-cell function [insulinogenic index (ΔI30/ΔG30), and ΔC30/ΔG30], and disposition index (DI) in the TODAY cohort of 704 youth (14.0 ± 2.0 yr; diabetes duration 7.8 ± 5.8 months; 64.9% female; 41.1% Hispanic, 31.5% Black, 19.6% White, 6.1% American Indian, and 1.7% Asian) according to hemoglobin A1c (HbA1c) quartiles at study randomization. The randomization visit followed a run-in period (median 71 d) during which glycemic control (HbA1c ≤ 8% for at least 2 months) was achieved with metformin alone. These measures were also examined in relation to screening HbA1c levels before run-in. RESULTS: Insulin secretion indices declined with increasing HbA1c quartiles, at randomization (ΔC30/ΔG30: 0.11 ± 0.09, 0.10 ± 0.19, 0.07 ± 0.06, and 0.03 ± 0.03 ng/mL per mg/dL, p < 0.0001; DI: 0.03 ± 0.03, 0.03 ± 0.05, 0.02 ± 0.02, and 0.01 ± 0.01 mg/dL(-1) , p < 0.0001) and at screening, with no significant difference in insulin sensitivity. There were no significant differences in estimates of insulin sensitivity or secretion between genders or across the different racial groups. At randomization and screening, HbA1c correlated with DI (r = -0.3, p < 0.001), with ΔC30/ΔG30, but not with insulin sensitivity estimates. CONCLUSIONS: In youth with recent-onset T2DM treated with metformin, glycemic control, as measured by HbA1c, appears to be associated with residual β-cell function and not insulin sensitivity.
Source: Pediatric Diabetes
Authors: Fida Bacha, Laura Pyle, Kristen Nadeau, Leona Cuttler, Robin Goland, Morey Haymond, Lynne Levitsky, Jane Lynch, Ruth S. Weinstock, Neil H. White, Sonia Caprio, Silva Arslanian, The TODAY Study Group
Institutions: Baylor College of Medicine, Children's Hospital of Pittsburgh, Children's Nutrition Research Center at Baylor College of Medicine, George Washington University, Children's Hospital Colorado, University of Colorado Denver, Rainbow Babies & Children's Hospital, Case Western Reserve University, Columbia University, Massachusetts General Hospital, The University of Texas at San Antonio Health Science Center, SUNY Upstate Medical University, Washington University in St. Louis, Yale University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: type 2 diabetes in youth, glycemic control, insulin sensitivity, insulin secretion, beta-cell function, disposition index, insulinogenic index, C-peptide, HbA1c, metformin, TODAY study, racial and ethnic differences, sex differences, recent-onset diabetes, insulin resistance, insulin resistance index
Open Access status: bronze
Funders: Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Sanofi, Massachusetts General Hospital, Yale University, Children's Hospital of Philadelphia, Children's Hospital Los Angeles, George Washington University, University of Washington, University of Oklahoma, Case Western Reserve University, BD, National Institutes of Health, University of Oklahoma Health Sciences Center, University of Colorado Denver, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources, National Center for Advancing Translational Sciences, Children's Hospital of Pittsburgh
Awards: G1320905697, General Clinical Research Center, Management of Pediatric Type 2 Diabetes Mellitus, Multi-Center Study of the Treatment of T2DM in Youth, Case Western Reserve University/Cleveland Clinic CTSA (UL1), G2427822680, Southern California Clinical and Translational Science Institute, G3314594697, Harvard Clinical and Translational Science Center (UL1), General Clinical Research Center, G3499161329, University of Pittsburgh Clinical and Translational Science Institute, G4012495729, G4113217758, Type 2 Diabetes in Youth: Beta Cell Preservation, Treatment Alternatives in Pediatric Type 2 Diabetes, TODAY2 Phase 2 (T2P2): Long-Term Post-Intervention Follow-Up, G523627176, G5308902211, G5318790011, Institutional Clinical and Translational Science Award, General Clinical Research Center, G606898507, General Clinical Research Center, General Clinical Research Center, G6304731611, Washington University Institute of Clinical and Translational Sciences, G7382394668, Washington University Institute of Clinical and Translational Sciences (UL1), Yale University Clinical and Translational Science Award Program, General Clinical Research Center, G889535532, The Washington University Center for Diabetes Translation Research, GENERAL CLINICAL RESEARCH CENTER, Colorado Clinical and Translational Science Institute (UL1)
OpenAlex ID: W1678947614
